Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Feb;35(2):e7.
doi: 10.2337/dc11-1995.

RS3PE in association with dipeptidyl peptidase-4 inhibitor: report of two cases

Keishi Yamauchi, Yuka Sato, Koh Yamashita, Yoshiko Funase, Taimei Kaneko, Takao Hashimoto, Toru Aizawa
Case Reports

RS3PE in association with dipeptidyl peptidase-4 inhibitor: report of two cases

Keishi Yamauchi et al. Diabetes Care. 2012 Feb.
No abstract available

PubMed Disclaimer

References

    1. McCarty DJ, O'Duffy JD, Pearson L, Hunter JB. Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA 1985;254:2763–2767 - PubMed
    1. Olivieri I, Salvarani C, Cantini F. RS3PE syndrome: an overview. Clin Exp Rheumatol 2000;18(Suppl. 20S53–S55 - PubMed
    1. Mattern T, Scholz W, Feller AC, Flad HD, Ulmer AJ. Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes. Scand J Immunol 1991;33:737–748 - PubMed
    1. Skandalis K, Spirova M, Gaitanis G, Tsartsarakis A, Bassukas I. Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin. J Eur Acad Dermatol Venereol. 6 April 2011. [Epub ahead of print] - PubMed
    1. Pasmatzi E, Monastirli A, Habeos J, Georgiou S, Tsambaos D. Dipeptidyl peptidase-4 inhibitors cause bullous pemphigoid in diabetic patients: report of two cases. Diabetes Care 2011;34:e133. - PMC - PubMed

Substances